Cancer Technologies, Inc.
United StatesFDA applicant, unverified
- Devices
- 4
What Cancer Technologies, Inc. makes
Cancer Technologies, Inc. produces kits for intravenous administration, including the Extravakit for radiological applications and the Extravakit for dimethylsulfoxide (DMSO), as well as the Tumorimeter—a device used for measuring tumor size.
These products are regulated under FDA’s 510(k) pathway, with devices classified as Class I and Class II. The company’s portfolio is listed in the FDA’s 510(k) clearance registry, and the manufacturer is based in the United States.
Catalogue
Extravakit For Radiological Applications Ref K883220
Regimes: 510(k) Registry: 510(k)Extravakit Ref K874807
Regimes: 510(k) Registry: 510(k)Extravakit For Dimethylsulfoxide (Dmso) Ref K883242
Regimes: 510(k) Registry: 510(k)Tumorimeter Ref K874352
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Cancer Technologies, Inc. have in the registry?
The registry currently lists 4 devices for Cancer Technologies, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Cancer Technologies, Inc.'s devices?
Among its 4 most recently registered devices, Cancer Technologies, Inc. has devices listed in FDA 510(k) (4 devices).
What risk classes do Cancer Technologies, Inc.'s devices fall under?
Among its 4 most recently registered devices, the classes recorded for Cancer Technologies, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Cancer Technologies, Inc. in the registry?
The most recently registered devices listed for Cancer Technologies, Inc. include EXTRAVAKIT FOR RADIOLOGICAL APPLICATIONS, EXTRAVAKIT, EXTRAVAKIT FOR DIMETHYLSULFOXIDE (DMSO) and TUMORIMETER.